Samiya Mohiuddin
Medical · Frederick, MDNPI 1912536186
Payments from drug & device makers
Across 195 payments — averaging $22.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$942
- Novo Nordisk$591
- AbbVie$571
- Astellas Pharma US Inc$357
- Boehringer Ingelheim$327
- Pfizer$270
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,27896%
- Education$2004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $942 |
| Novo Nordisk | 29 | $591 |
| AbbVie | 36 | $571 |
| Astellas Pharma US Inc | 11 | $357 |
| Boehringer Ingelheim | 13 | $327 |
| Pfizer | 12 | $270 |
| Lilly USA, LLC | 14 | $258 |
| GSK | 7 | $218 |
| Exact Sciences | 8 | $184 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $109 |
| E.r. Squibb & Sons, L.L.C. | 2 | $94 |
| ANI Pharmaceuticals, Inc. | 3 | $82 |
| Daiichi Sankyo Inc. | 3 | $71 |
| Johnson & Johnson | 3 | $60 |
| Bayer | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Xeris Pharmaceuticals, Inc. | 3 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| Merck | 2 | $31 |
| Gilead | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Amgen | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $14 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,478 in reported general payments places this provider in the 80th percentile of 543 medical providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 64 | $61,631 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $49,039 |
| EliquisApixaban | 29 | $38,949 |
| JardianceEmpagliflozin | 33 | $29,001 |
| FarxigaDapagliflozin Propanediol | 22 | $21,676 |
| JanuviaSitagliptin Phosphate | 17 | $18,305 |
| MounjaroTirzepatide | 17 | $18,243 |
| XareltoRivaroxaban | 20 | $18,064 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 18 | $11,666 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $5,917 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $4,695 |
| Arnuity ElliptaFluticasone Furoate | 12 | $3,977 |
| Gabapentin | 132 | $2,203 |
| Atorvastatin Calcium | 205 | $2,009 |
| Famotidine | 90 | $1,655 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $591 | $61,63164 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $218 | $58,93378 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $327 | $40,66751 claims |
| PfizerEliquis | $270 | $38,94929 claims |
| AstraZenecaFarxiga | $942 | $21,67622 claims |
| MerckJanuvia | $31 | $18,30517 claims |
| Lilly USA, LLCMounjaro | $258 | $18,24317 claims |
| Johnson & JohnsonXarelto | $60 | $18,06420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 543 medical providers in Maryland.
Other medical in Frederick
- Kristina TrunnellFrederick$51K
- Sarah JamiesonFrederick$34K
- Evelyn ChavezFrederick$8K
- Collina AfriyieFrederick$7K
- Victoria TrottStevensville$94K
- Sarah SagorskyBaltimore$68K
- Emily GrisnikLeonardtown$62K
- Jennifer HamiltonBel Air$52K
- Karen ScottAnnapolis$49K
- Nicholas WunderAberdeen$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.